(Flumist, the nasal flu vaccine,
was found to be ineffective and is not recommended.).
These new studies found that Flumist offered kids virtually no protection against the flu.
The decision is a reversal of fortune for Flumist, which is made by AstraZeneca
and was first licensed in 2003.
Bhowmick: Flumist, which can be given to people ages 2 to 49,
contains a live virus and is effective if administered properly.
Bhowmick: Flumist, which can be given to people aged 2 to 49,
contains a live virus and is effective if administered properly.
Flumist differs from the traditional shot in that it is not
made from dead virus, but from a weakened form of the influenza virus.
That's because the medicine, called Flumist, has been largely ineffective in children in recent years
and should not be used in the United States during the 2016-17 flu season, the panel of experts said.